• OPEN AN ACCOUNT
Indian Indices
Sensex
76,909.68 -325.78
( -0.42%)
Global Indices
Nasdaq
53,487.79 123.39
(0.23%)
Dow Jones
7,729.14 16.38
(0.21%)
Hang Seng
65,335.94 -2,124.79
(-3.15%)
Nikkei 225
10,747.45 19.41
(0.18%)
Forex
USD-INR
95.60 0.07
(0.07%)
EUR-INR
110.76 0.24
(0.21%)
GBP-INR
129.56 0.29
(0.22%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
337.9869392
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
45.95
46287.32
EPS(TTM)
Face Value()
Div & Yield %
80.61
2
0.76
 

emco ltd
Surya Roshni consolidated net profit declines 24.44% in the March 2026 quarter
May 25,2026
Net profit of Surya Roshni declined 24.44% to Rs 98.30 crore in the quarter ended March 2026 as against Rs 130.09 crore during the previous quarter ended March 2025. Sales rose 0.81% to Rs 2163.25 crore in the quarter ended March 2026 as against Rs 2145.83 crore during the previous quarter ended March 2025.

For the full year,net profit declined 17.54% to Rs 285.81 crore in the year ended March 2026 as against Rs 346.60 crore during the previous year ended March 2025. Sales rose 1.41% to Rs 7540.42 crore in the year ended March 2026 as against Rs 7435.87 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2163.252145.83 1 7540.427435.87 1
OPM %7.149.43 -6.467.79 -
PBDT163.91206.62 -21 513.69588.15 -13
PBT131.01175.48 -25 383.72465.41 -18
NP98.30130.09 -24 285.81346.60 -18